Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Diamondback Energy Inc. Stock Slides 8.0%, Underperforms Peers

Diamondback Energy Inc. Stock Slides 8.0%, Underperforms Peers

Dow JonesDow Jones2026/09/16 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Diamondback Energy Inc. shed 8.0% to $194.54 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.4% to 7,551.81 and Dow Jones Industrial Average falling 1.2% to 51,461.90.

The stock's fall snapped a two-day winning streak.

Diamondback Energy Inc. closed 10.3% short of its 52-week high of $216.90, which the company reached on August 20th.

The stock underperformed when compared to some of its peers, as EOG Resources Inc. fell 5.7% to $144.93, Devon Energy Corp. fell 5.6% to $48.44, and Occidental Petroleum Corp. fell 6.55% to $59.36.

Trading volume totaled 15.2 million, compared to the 50-day average of 1.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 16, 2026 16:33 ET (20:33 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks